HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.65
Day range
$0.63 - $0.63
Year range
$0.57 - $1.14
Market cap
57.83M CAD
Avg Volume
25.93K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
The New York Times
12 hours ago
Stocks Extend ‘Astonishing’ Rally as Middle East Tensions Ease Further
1.20%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.34M | -10.04% |
Net income | -1.40M | 9.77% |
Net profit margin | — | — |
Earnings per share | -0.02 | -5.26% |
EBITDA | -1.28M | 12.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.14M | 205.43% |
Total assets | 4.08M | 67.27% |
Total liabilities | 1.32M | 94.85% |
Total equity | 2.76M | — |
Shares outstanding | 87.29M | — |
Price to book | 21.67 | — |
Return on assets | -99.20% | — |
Return on capital | -145.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.40M | 9.77% |
Cash from operations | -1.17M | 32.33% |
Cash from investing | -9.00K | 80.00% |
Cash from financing | 2.27M | 1,183.62% |
Net change in cash | 1.16M | 163.36% |
Free cash flow | -2.20M | -68.14% |
About
Founded
2011
Website
Employees
9
